Nature Reviews Critiques AI in Drug Discovery: Absence of Clinical Evidence
EricTopol · x · 2026-08-09
Eric Topol shares an in-depth review from Nature Reviews Drug Discovery assessing a decade of AI in drug discovery. The authors conclude that the field is still at a stage with an 'absence of evidence' when it comes to translating AI into clinically relevant impact.
Related event: Nature Review: AI Drug Discovery Lacks Clinical Impact(2 posts)→
More from Research
- Netflix details its production LLM judge: hundreds of thousands of recommendations scored weekly — omarsar0 · 2026-08-24
- Nature Comment: Provenance, not interpretability, grounds trust in autonomous science — gabepgomes · 2026-08-24
- New Architecture RHEA: Train 1B Model on 8GB VRAM — zemondza · 2026-08-24
- Trained two 16M-param models to do generative CAD with real physics — debreuil · 2026-08-24
- Claude model helps discover complex structure on S^6, solving 60-year-old math problem — Singularitarian · 2026-08-24
- Study: Agents read instructions/notes 60.5% of the time, rarely touch API docs — dair_ai · 2026-08-24